TRANSACTION RECORD

DOWNLOAD RECORD   vCard | CSV | PDF
Company Name KAI Pharmaceuticals
Status Acquired or Merged
Industry Biopharmaceutical
Company Description KAI Pharmaceuticals is a biology-based product-driven pharmaceutical company developing a new class of therapeutics targeting cell-signaling enzymes that affect numerous disease pathways. The company is leveraging its leadership position in protein kinase C (PKC), an important and validated family of kinases, to rapidly advance product candidates into human clinical trials.
Mailing Address 270 Littlefield Avenue 
South San Francisco, CA 94080
USA  Map
Phone (650) 244-1100
Website www.kaipharmaceuticals.com
Email Click for Free Trial
Profile
Social Media
Company News
Facebook
YouTube
 
Company Management
Title Name Email Profile
     
Chief Executive Officer James, Steven
Chief Medical Officer Bell, Gregory
VP - Product Management Wilson, Susan
VP - R & D Johnson, Randolph
Information Release Date 12/3/2003
Transaction Type Venture Equity
Amount $17,000,000
Round Series A
Proceeds Purposes This successful financing positions KAI to emerge as one of the most exciting new biotechnology companies.
Transaction Investors
Skyline Ventures
(Lead Investor)
InterWest Partners
Intersouth Partners
Delphi Ventures

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.


PCI - Level1